Catalyst Wire Dossier Catalyst Wire Dossier

Imrecoxib

Imrecoxib · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Imrecoxib, covering 2013-11-15 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency [Phase 1]

See pricing